| Literature DB >> 33159918 |
Keerthana Deepti Karunakaran1, Ke Peng2, Delany Berry3, Stephen Green3, Robert Labadie3, Barry Kussman4, David Borsook5.
Abstract
Current pain assessment techniques based only on clinical evaluation and self-reports are not objective and may lead to inadequate treatment. Having a functional biomarker will add to the clinical fidelity, diagnosis, and perhaps improve treatment efficacy in patients. While many approaches have been deployed in pain biomarker discovery, functional near-infrared spectroscopy (fNIRS) is a technology that allows for non-invasive measurement of cortical hemodynamics. The utility of fNIRS is especially attractive given its ability to detect specific changes in the somatosensory and high-order cortices as well as its ability to measure (1) brain function similar to functional magnetic resonance imaging, (2) graded responses to noxious and innocuous stimuli, (3) analgesia, and (4) nociception under anesthesia. In this review, we evaluate the utility of fNIRS in nociception/pain with particular focus on its sensitivity and specificity, methodological advantages and limitations, and the current and potential applications in various pain conditions. Everything considered, fNIRS technology could enhance our ability to evaluate evoked and persistent pain across different age groups and clinical populations.Entities:
Keywords: Acute pain; Analgesics; Anesthesia; BA10; Biomarker; Brain; Chronic pain; Depression; Machine learning; Morphine; Near infrared spectroscopy; Opioids; Polarfrontal cortex; S1 cortex; Somatosensory; cortex
Mesh:
Year: 2020 PMID: 33159918 DOI: 10.1016/j.neubiorev.2020.10.023
Source DB: PubMed Journal: Neurosci Biobehav Rev ISSN: 0149-7634 Impact factor: 9.052